Person profile
Roles
Address
Research Triangle Park, North Carolina
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Viridian Therapeutics, Inc.\DE
28 Jun 24
4
Viridian Therapeutics, Inc.\DE
16 Jun 23
4
G1 Therapeutics, Inc.
5 Jan 23
4
Viridian Therapeutics, Inc.\DE
10 Jun 22
4
G1 Therapeutics, Inc.
2 Feb 22
4
G1 Therapeutics, Inc.
5 Jan 22
4
Viridian Therapeutics, Inc.\DE
15 Jul 21
3
Viridian Therapeutics, Inc.\DE
15 Jul 21
4
G1 Therapeutics, Inc.
4 Mar 21
4
G1 Therapeutics, Inc.
5 Jan 21
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 26 Jun 24 | VRDN Viridian Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 12.31 | 21,000 | 258.51 k | 21,000 |
| 14 Jun 23 | VRDN Viridian Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 27.67 | 20,000 | 553.40 k | 20,000 |